감염증 체외진단 시장 규모, 점유율, 성장 분석 : 제품 유형별, 기술별, 질환 유형별, 용도별, 최종사용자별, 검사 실시 장소별, 지역별 - 업계 예측(2026-2033년)

Global Infectious Disease In Vitro Diagnostics Market size was valued at USD 24.5 Billion in 2024 and is poised to grow from USD 25.25 Billion in 2025 to USD 32.19 Billion by 2033, growing at a CAGR of 3.08% during the forecast period (2026-2033).

The global infectious disease in vitro diagnostics market is driven by the critical need for effective pathogen detection in clinical specimens, which is essential for enhancing patient care and public health strategies. The demand for rapid and precise molecular assays has surged, propelled by innovations in PCR, next-generation sequencing, and multiplex technologies that facilitate testing in point-of-care environments. These advancements have prompted investment in automated platforms and streamlined reporting processes, fostering regulatory support and payer recognition of diagnostic value. AI technologies further enhance diagnostic accuracy by analyzing complex data patterns, enabling improved pathogen identification, and generating actionable susceptibility insights. This collaborative innovation is revolutionizing decentralized testing approaches in emerging markets, leading to a significant shift towards integrated, value-based diagnostic solutions that ultimately aim to optimize healthcare outcomes.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Infectious Disease In Vitro Diagnostics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Infectious Disease In Vitro Diagnostics Market Segments Analysis

Global infectious disease in vitro diagnostics market is segmented by by product type, by technology, by disease type, by application, by end user, by test location and region. Based on by product type, the market is segmented into Reagents & Kits, Instruments, Software & Data Management Solutions and Others. Based on by technology, the market is segmented into Molecular Diagnostics, Immunodiagnostics, Clinical Microbiology, Point-of-care Testing and Others. Based on by disease type, the market is segmented into Viral Infections, Bacterial Infections, Fungal Infections and Parasitic Infections. Based on by application, the market is segmented into Disease Screening, Disease Diagnosis, Treatment Monitoring, Blood Screening and Others. Based on by end user, the market is segmented into Hospitals, Diagnostic Laboratories, Academic & Research Institutes, Blood Banks and Others. Based on by test location, the market is segmented into Laboratory Testing, Point-of-care Testing and Home-based Testing. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Infectious Disease In Vitro Diagnostics Market

The Global Infectious Disease In Vitro Diagnostics market is fueled by ongoing advancements in assay sensitivity, multiplexing capabilities, and automation, which facilitate a wider detection of pathogens while optimizing laboratory workflows. These enhanced platforms significantly decrease sample-to-answer times and accommodate various specimen types, motivating laboratories and clinicians to incorporate more in vitro diagnostic solutions into standard procedures. By simplifying operational processes and increasing reproducibility, these technological innovations help to alleviate implementation challenges and build trust among end users and healthcare systems. Consequently, this progression supports continued market growth driven by the increasing demand for dependable and comprehensive infectious disease testing.

Restraints in the Global Infectious Disease In Vitro Diagnostics Market

The complexity of fragmented regulatory requirements around the globe poses significant challenges for the Global Infectious Disease In Vitro Diagnostics market. These varying standards complicate the product development and market entry processes, resulting in increased time and resources needed for obtaining necessary approvals. Manufacturers face a labyrinth of validation criteria, submission protocols, and post-market responsibilities, often diverting focus from innovation to compliance. This intricate landscape can deter smaller companies from entering certain markets, which in turn delays the introduction of advanced diagnostic assays in various regions. Consequently, the overall market expansion is impeded, as the pace of new technology adoption in clinical settings is slowed.

Market Trends of the Global Infectious Disease In Vitro Diagnostics Market

The Global Infectious Disease In Vitro Diagnostics market is witnessing a significant trend towards point-of-care expansion, as healthcare providers increasingly adopt rapid, decentralized testing methods. This shift enhances access and facilitates timely clinical decisions, with an emphasis on compact and user-friendly platforms that deliver reliable results outside traditional laboratory environments. Manufacturers are prioritizing streamlined workflows, aligning with regulatory standards, and forming strategic partnerships with primary care networks to scale deployment effectively. This evolving landscape promotes broader testing coverage, minimizes diagnostic delays, and extends market opportunities into outpatient, emergency, and resource-limited settings where laboratory infrastructure is often inadequate.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Infectious Disease In Vitro Diagnostics Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Reagents & Kits
  • PCR Reagents & Kits
  • Immunoassay Reagents & Kits
  • Rapid Test Kits
  • Others
• Instruments
  • PCR Systems
  • Immunoassay Analyzers
  • Sequencing Systems
  • Others
• Software & Data Management Solutions
• Others

Global Infectious Disease In Vitro Diagnostics Market Size by Technology & CAGR (2026-2033)

• Market Overview
• Molecular Diagnostics
  • PCR-based Testing
  • Isothermal Nucleic Acid Amplification
  • Next-generation Sequencing
  • Others
• Immunodiagnostics
• Clinical Microbiology
• Point-of-care Testing
• Others

Global Infectious Disease In Vitro Diagnostics Market Size by Disease Type & CAGR (2026-2033)

• Market Overview
• Viral Infections
  • HIV
  • Hepatitis
  • Influenza
  • COVID-19
  • Others
• Bacterial Infections
• Fungal Infections
• Parasitic Infections

Global Infectious Disease In Vitro Diagnostics Market Size by Application & CAGR (2026-2033)

• Market Overview
• Disease Screening
• Disease Diagnosis
• Treatment Monitoring
• Blood Screening
• Others

Global Infectious Disease In Vitro Diagnostics Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Diagnostic Laboratories
• Academic & Research Institutes
• Blood Banks
• Others

Global Infectious Disease In Vitro Diagnostics Market Size by Test Location & CAGR (2026-2033)

• Market Overview
• Laboratory Testing
• Point-of-care Testing
• Home-based Testing

Global Infectious Disease In Vitro Diagnostics Market Size & CAGR (2026-2033)

• North America (By Product Type, By Technology, By Disease Type, By Application, By End User, By Test Location)
  • US
  • Canada
• Europe (By Product Type, By Technology, By Disease Type, By Application, By End User, By Test Location)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (By Product Type, By Technology, By Disease Type, By Application, By End User, By Test Location)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (By Product Type, By Technology, By Disease Type, By Application, By End User, By Test Location)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (By Product Type, By Technology, By Disease Type, By Application, By End User, By Test Location)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Roche Diagnostics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• bioMerieux
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QIAGEN
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton Dickinson
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hologic
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sysmex Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• OraSure Technologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cepheid
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Grifols
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QuidelOrtho
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Seegene
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mindray Medical International
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fujirebio
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations